The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects
|
|---|---|
| Published in |
Journal of Cancer Research and Clinical Oncology, March 2009
|
| DOI | 10.1007/s00432-009-0562-z |
| Pubmed ID | |
| Authors |
Gary Deng, Hong Lin, Andrew Seidman, Monica Fornier, Gabriella D’Andrea, Kathleen Wesa, Simon Yeung, Susanna Cunningham-Rundles, Andrew J. Vickers, Barrie Cassileth |
| Abstract |
Cancer patients commonly use dietary supplements to "boost immune function". A polysaccharide extract from Grifola frondosa (Maitake extract) showed immunomodulatory effects in preclinical studies and therefore the potential for clinical use. Whether oral administration in human produces measurable immunologic effects, however, is unknown. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 25% |
| Spain | 1 | 25% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 176 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 2% |
| Japan | 1 | <1% |
| France | 1 | <1% |
| Unknown | 170 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 27 | 15% |
| Researcher | 26 | 15% |
| Student > Bachelor | 19 | 11% |
| Other | 16 | 9% |
| Student > Ph. D. Student | 13 | 7% |
| Other | 33 | 19% |
| Unknown | 42 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 44 | 25% |
| Agricultural and Biological Sciences | 24 | 14% |
| Biochemistry, Genetics and Molecular Biology | 19 | 11% |
| Nursing and Health Professions | 8 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 4% |
| Other | 24 | 14% |
| Unknown | 50 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 71. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2024.
All research outputs
#634,397
of 26,237,895 outputs
Outputs from Journal of Cancer Research and Clinical Oncology
#16
of 2,882 outputs
Outputs of similar age
#1,359
of 111,133 outputs
Outputs of similar age from Journal of Cancer Research and Clinical Oncology
#1
of 11 outputs
Altmetric has tracked 26,237,895 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,882 research outputs from this source. They receive a mean Attention Score of 3.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 111,133 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.